BioNTech
Francis Wittmann is an accomplished Project Quality Manager at BioNTech SE since July 2022, leading the Inspection Readiness Program for the Marburg site. Prior experience includes significant roles at GSK from March 2014 to July 2022, such as Site Implementation Lead overseeing global Tech Transfer for the Zoster project and Manager Validation Lifecycle responsible for FDA lifecycle management at the Marburg site. Experience also encompasses a tenure as Manager Process Validation, guiding a team in process validation and ensuring compliance with global regulatory standards. Earlier roles at Novartis from March 2006 to February 2014 included Validation Engineer and Process Specialist, focusing on validation activities and GMP upgrades. Francis began the career at Merck KGaA as a Chemielaborantin in research and development, following education at Heinrich-Emanuel-Merck-Schule Darmstadt, where a degree in Chemielaborantin was obtained.
This person is not in any teams
This person is not in any offices
BioNTech
32 followers
BioNTech was founded in 2008 on the understanding that every cancer patient’s treatment should be individualized. Their vision is to provide patient-specific immunotherapies worldwide.